Schedule III
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
1.
Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:
CA: Currently at CDSA Schedule I Section 19 Amphetamines
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(1)
Amphetamine (α-Methylbenzeneethanamine)
UK: MDA Part II Class B Section 1(a) Amphetamine
UN: Psychotropics Schedule II Amfetamine (Amphetamine)
US: CSA Schedule II Section d Subsection 1 Amphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 1 Amphetamine
⇒
PubChem: 3007; ChemSpider: 13852819; Bluelight: Amphetamine; Drugs Forum: Amphetamine; Erowid: Amphetamine; Wikipedia: AmphetamineEffective 10 Aug 2005, SOR/2005-235 revoked:
(2)
Methamphetamine (N,ɑ-Dimethylbenzeneethanamine)
CA: Currently at CDSA Schedule I Section 18 Methamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(3)
N-Ethylamphetamine (N-Ethyl-α-methylbenzeneethanamine)
UK: MDA Part III Class C Section 1(a) N-Ethylamphetamine
UN: Psychotropics Schedule IV Etilamfetamine (N-Ethylamphetamine)
US: CSA Schedule I Section f Subsection 7 N-Ethylamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 2 N-Ethylamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(4)
4-Methyl-2,5-dimethoxyamphetamine (2,5-Dimethoxy-4,α-dimethylbenzeneethanamine)
UK: MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine and Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
UN: Psychotropics Schedule I STP (DOM)
US: CSA Schedule I Section d Subsection 9 4-Methyl-2,5-dimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(5)
3,4-Methylenedioxyamphetamine (MDA) (α-Methyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) 3,4-Methylenedioxyamphetamine
UN: Psychotropics Schedule I Tenamfetamine (MDA)
US: CSA Schedule I Section d Subsection 10 3,4-Methylenedioxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 4 3,4-Methylenedioxyamphetamine (MDA)
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(6)
2,5-Dimethoxyamphetamine (2,5-Dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyamphetamine
UN: Psychotropics Schedule I DMA
US: CSA Schedule I Section d Subsection 4 2,5-Dimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 5 2,5-Dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(7)
4-Methoxyamphetamine (4-Methoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Methoxyamphetamine
UN: Psychotropics Schedule I PMA
US: CSA Schedule I Section d Subsection 7 4-Methoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 6 4-Methoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(8)
2,4,5-Trimethoxyamphetamine (2,4,5-Trimethoxy-α-methylbenzeneethanamine)
EU: Substances Substances TMA-2
UK: MDA Part I Class A Section 1(c) 2,4,5-Trimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 7 2,4,5-Trimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(9)
N-Methyl-3,4-methylenedioxyamphetamine (N,α-Dimethyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) N-Methyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDMA
US: CSA Schedule I Section d Subsection 11 3,4-Methylenedioxymethamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 8 N-Methyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(10)
4-Ethoxy-2,5-dimethoxyamphetamine (4-Ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Ethoxy-2,5-dimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 9 4-Ethoxy-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(11)
5-Methoxy-3,4-methylenedioxyamphetamine (7-Methoxy-α-methyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) 5-Methoxy-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MMDA
US: CSA Schedule I Section d Subsection 8 5-Methoxy-3,4-methylenedioxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 10 5-Methoxy-3,4-methylenedioxyamphetamine
⇒
PubChem: 26175; ChemSpider: 24386; Drugs Forum: MMDA; PiHKAL • info: MMDA; Wikipedia: MMDA (psychedelic)
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(12)
N,N-Dimethyl-3,4-methylenedioxyamphetamine (N,N,α-Trimethyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(ba) Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
CA: Currently at CDSA Schedule I Section 19 Subsection 11 N,N-Dimethyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(13)
N-Ethyl-3,4-methylenedioxyamphetamine (N-Ethyl-α-methyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) N-Ethyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDE (N-Ethyl MDA)
US: CSA Schedule I Section d Subsection 12 3,4-Methylenedioxy-N-ethylamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 12 N-Ethyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(14)
4-Ethyl-2,5-dimethoxyamphetamine (4-Ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I DOET
US: CSA Schedule I Section d Subsection 5 2,5-Dimethoxy-4-ethylamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 13 4-Ethyl-2,5-dimethoxyamphetamine
⇒
PubChem: 27402; ChemSpider: 25499; PiHKAL • info: DOET; Wikipedia: 2,5-Dimethoxy-4-ethylamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(15)
4-Bromo-2,5-dimethoxyamphetamine (4-Bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine and Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
US: CSA Schedule I Section d Subsection 2 4-Bromo-2,5-dimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(16)
4-Chloro-2,5-dimethoxyamphetamine (4-Chloro-2,5-dimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Chloro-2,5-dimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 15 4-Chloro-2,5-dimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(17)
4-Ethoxyamphetamine (4-Ethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 4-Ethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 16 4-Ethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(18)
Benzphetamine (N-Benzyl-N,α-dimethylbenzeneethanamine)
UK: MDA Part III Class C Section 1(a) Benzphetamine
UN: Psychotropics Schedule IV Benzfetamine (Benzphetamine)
US: CSA Schedule III Section b Subsection 2 Benzphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 17 Benzphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
(19)
N-Propyl-3,4-methylenedioxyamphetamine (α-Methyl-N-propyl-1,3-benzodioxole-5-ethanamine)
UK: MDA Part I Class A Section 1(c) N-Propyl-3,4-methylenedioxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 18 N-Propyl-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
Effective 22 Apr 1997, SOR/97-230 added:
(20)
N-(2-Hydroxyethyl)-α-methylbenzeneethanamine
CA: Currently at CDSA Schedule I Section 19 Subsection 19 N-(2-Hydroxyethyl)-α-methylbenzeneethanamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
Effective 30 Jan 2003, SOR/2003-32 added:
(21)
N-Hydroxy-3,4-methylenedioxyamphetamine (N-[α-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
UK: MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine and Section 1(f) N-Hydroxytenamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
US: CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
Effective 30 Jan 2003, SOR/2003-32 added:
(22)
3,4,5-Trimethoxyamphetamine (3,4,5-Trimethoxy-α-methylbenzeneethanamine)
UK: MDA Part I Class A Section 1(c) 3,4,5-Trimethoxyamphetamine
UN: Psychotropics Schedule I TMA
US: CSA Schedule I Section d Subsection 14 3,4,5-Trimethoxyamphetamine
CA: Currently at CDSA Schedule I Section 19 Subsection 21 3,4,5-Trimethoxyamphetamine
⇒
PubChem: 31016; ChemSpider: 28775; Bluelight: TMA and isomers; Drugs Forum: TMA 2; Erowid: TMA-2 (and other TMAs); PiHKAL • info: TMA; Wikipedia: Trimethoxyamphetamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
Effective 10 Aug 2005, SOR/2005-235 added:
(23)
Methamphetamine (N,α-Dimethylbenzeneethanamine)
UK: MDA Part I Class A Section 1(a) Methylamphetamine
UN: Psychotropics Schedule II Metamfetamine racemate (Methamphetamine racemate)
US: CSA Schedule II Section d Subsection 2 Methamphetamine
CA: Currently at CDSA Schedule I Section 18 Methamphetamine
⇒
PubChem: 1206; ChemSpider: 1169; Bluelight: Methamphetamine; Drugs Forum: Methamphetamine; Erowid: Meth; Wikipedia: Methamphetamine
2.
Methylphenidate (α-Phenyl-2-piperidineacetic acid methyl ester) and any salt thereof
Effective 22 Apr 1997, SOR/97-230 replacement for:
Methylphenidate (α-Phenyl-2-pyridineacetic acid methyl ester) and any salt thereof
UK: MDA Part II Class B Section 1(a) Methylphenidate
UN: Psychotropics Schedule II Methylphenidate
US: CSA Schedule II Section d Subsection 4 Methylphenidate
⇒
PubChem: 4158; ChemSpider: 4015; Bluelight: Methylphenidate; Drugs Forum: Methylphenidate; Erowid: Methylphenidate; Wikipedia: Methylphenidate
3.
Methaqualone (2-Methyl-3-(2-methylphenyl)-4(3H)-quinazolinone) and any salt thereof
UK: MDA Part II Class B Section 1(a) Methaqualone
UN: Psychotropics Schedule II Methaqualone
US: CSA Schedule I Section e Subsection 3 Methaqualone
⇒
PubChem: 6292; ChemSpider: 6055; Bluelight: Methaqualone; Drugs Forum: Methaqualone; Erowid: Methaqualone; Wikipedia: Methaqualone
4.
Mecloqualone (2-Methyl-3-(2-chlorophenyl)-4(3H)-quinazolinone) and any salt thereof
UK: MDA Part II Class B Section 1(a) Mecloqualone
UN: Psychotropics Schedule II Mecloqualone
US: CSA Schedule I Section e Subsection 2 Mecloqualone
5.
Lysergic acid diethylamide (N,N-Diethyllysergamide) and any salt thereof
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
6.
N,N-Diethyltryptamine (3-[(2-Diethylamino)ethyl]indole) and any salt thereof
UK: MDA Part I Class A Section 1(a) N,N-Diethyltryptamine
UN: Psychotropics Schedule I DET
US: CSA Schedule I Section d Subsection 18 Diethyltryptamine
7.
N,N-Dimethyltryptamine (3-[(2-Dimethylamino)ethyl]indole) and any salt thereof
UK: MDA Part I Class A Section 1(a) N,N-Dimethyltryptamine
UN: Psychotropics Schedule I DMT
US: CSA Schedule I Section d Subsection 19 Dimethyltryptamine
8.
N-Methyl-3-piperidyl benzilate (LBJ) (3-[(Hydroxydiphenylacetyl)oxy]-1-methylpiperidine) and any salt thereof
US: CSA Schedule I Section d Subsection 28 N-Methyl-3-piperidyl benzilate
9.
Harmaline (4,9-Dihydro-7-methoxy-1-methyl-3H-pyrido[3,4-b]indole) and any salt thereof
⇒
PubChem: 5280951; ChemSpider: 10211258; Erowid: Harmala Alkaloids; TiHKAL • info: Harmaline; Wikipedia: Harmaline
11.
Psilocin (3-[2-(Dimethylamino)ethyl]-4-hydroxyindole) and any salt thereof
UK: MDA Part I Class A Section 1(a) Psilocin
UN: Psychotropics Schedule I Psilocine (Psilotsin)
US: CSA Schedule I Section d Subsection 30 Psilocyn
12.
Psilocybin (3-[2-(Dimethylamino)ethyl]-4-phosphoryloxyindole) and any salt thereof
UK: MDA Part I Class A Section 1(b) Psilocybin
UN: Psychotropics Schedule I Psilocybine
US: CSA Schedule I Section d Subsection 29 Psilocybin
⇒
PubChem: 10624; ChemSpider: 10178; Drugs Forum: 4-H2PO4-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-H2PO4-DMT; Wikipedia: Psilocybin
13.
N-(1-Phenylcyclohexyl)ethylamine and any salt thereof
UK: MDA Part I Class A Section 1(a) Eticyclidine
UN: Psychotropics Schedule I Eticyclidine (PCE)
US: CSA Schedule I Section d Subsection 32 Ethylamine analog of Phencyclidine
![3D rendering of 1-[1-(2-Thienyl)cyclohexyl]piperidine](data:image/png;base64,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 "Click for a 3D rendering of 1-[1-(2-Thienyl)cyclohexyl]piperidine")
14.
1-[1-(2-Thienyl)cyclohexyl]piperidine and any salt thereof
UK: MDA Part I Class A Section 1(a) Tenocyclidine
UN: Psychotropics Schedule I Tenocyclidine (TCP)
US: CSA Schedule I Section d Subsection 34 Thiophene analog of Phencyclidine
⇒
PubChem: 62751; ChemSpider: 56495; Bluelight: PCP analogs; Drugs Forum: Tenocyclidine; Wikipedia: Tenocyclidine
15.
1-Phenyl-N-propylcyclohexanamine and any salt thereof
UK: MDA Part II Class B Section 1(d) 1-Phenyl-N-propylcyclohexanamine
16.
Rolicyclidine (1-(1-Phenylcyclohexyl)pyrrolidine) and any salt thereof
Effective 30 Jan 2003, SOR/2003-32 replacement for:
1-(1-Phenylcyclohexyl)pyrrolidine and any salt thereof
UK: MDA Part I Class A Section 1(a) Rolicyclidine
UN: Psychotropics Schedule I Rolicyclidine (PHP) (PCPY)
US: CSA Schedule I Section d Subsection 33 Pyrrolidine analog of Phencyclidine
⇒
PubChem: 62436; ChemSpider: 56218; Bluelight: PCP analogs; Drugs Forum: PCP analogs; Erowid: Rolicyclidine synthesis; Wikipedia: Rolicyclidine
17.
Mescaline (3,4,5-Trimethoxybenzeneethanamine) and any salt thereof, but not Lophophora
18.
4-Methylaminorex (4,5-Dihydro-4-methyl-5-phenyl-2-oxazolamine) and any salt thereof
UK: MDA Part I Class A Section 1(a) 4-Methyl-aminorex
UN: Psychotropics Schedule I 4-Methylaminorex
US: CSA Schedule I Section f Subsection 6 (±)-cis-4-Methylaminorex
⇒
PubChem: 92196; ChemSpider: 83237; Drugs Forum: 4-MAR; Erowid: 4-Methyl-aminorex; Wikipedia: 4-Methylaminorex
20.
Fenetylline (dl-3,7-Dihydro-1,3-dimethyl-7-(2-[(1-methyl-2-phenethyl)amino]ethyl)-1H-purine-2,6-dione) and any salt thereof
UK: MDA Part III Class C Section 1(a) Fenethylline
UN: Psychotropics Schedule II Fenetylline
US: CSA Schedule I Section f Subsection 4 Fenethylline
21.
2-Methylamino-1-phenyl-1-propanone and any salt thereof
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone![3D rendering of 1-[1-(Phenylmethyl)cyclohexyl]piperidine](data:image/png;base64,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 "Click for a 3D rendering of 1-[1-(Phenylmethyl)cyclohexyl]piperidine")
![3D rendering of 1-[1-(4-Methylphenyl)cyclohexyl]piperidine](data:image/png;base64,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 "Click for a 3D rendering of 1-[1-(4-Methylphenyl)cyclohexyl]piperidine")
23.
1-[1-(4-Methylphenyl)cyclohexyl]piperidine and any salt thereof
UK: MDA Part II Class B Section 1(d) 1-[1-(4-Methylphenyl)cyclohexyl]piperidine
Effective 22 Apr 1997, SOR/97-230 added:
24.
4-Bromo-2,5-dimethoxybenzeneethanamine and any salt, isomer or salt of isomer thereof
UK: MDA Part I Class A Section 1(c) 4-Bromo-2,5-dimethoxyphenethylamine
UN: Psychotropics Schedule II 2 C-B
US: CSA Schedule I Section d Subsection 3 4-Bromo-2,5-dimethoxyphenethylamine
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
25.
Flunitrazepam (5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any salts or derivatives thereof
Effective 1 Jun 2000, SOR/2000-220 replacement for:
On 27 Mar 1999, C. Gaz. 1999.I.926 proposed replacement for:
Effective 19 Mar 1998, SOR/98-173 added:
Flunitrazepam (5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one)
UK: MDA Part III Class C Section 1(a) Flunitrazepam
UN: Psychotropics Schedule III Flunitrazepam
US: CSA Schedule IV Section c Subsection 23 Flunitrazepam
CA: Currently at CDSA Schedule I Section 20 Flunitrazepam
⇒
PubChem: 3380; ChemSpider: 3263; Drugs Forum: Flunitrazepam; Erowid: Flunitrazepam; Wikipedia: Flunitrazepam
Effective 6 Nov 2012, S.C. 2012, c. 1 revoked:
On 20 Sep 2011, Bill C-10, 1st Sess., 41st Parl. proposed to revoke:
Effective 19 Mar 1998, SOR/98-173 added:
26.
4-Hydroxybutanoic acid and any salt thereof
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
CA: Currently at CDSA Schedule I Section 21 4-Hydroxybutanoic acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Effective 30 Jan 2003, SOR/2003-32 added:
27.
Effective 30 Jan 2003, SOR/2003-32 added:
28.
Etryptamine (3-(2-Aminobutyl)indole) and any salt thereof
UK: MDA Part I Class A Section 1(a) Etryptamine
UN: Psychotropics Schedule I Etryptamine
US: CSA Schedule I Section d Subsection 1 Alpha-ethyltryptamine
Effective 30 Jan 2003, SOR/2003-32 added:
29.
Lefetamine ((–)-N,N-Dimethyl-α-phenylbenzeneethanamine) and any salt thereof
UK: MDA Part II Class B Section 1(a) Lefetamine
UN: Psychotropics Schedule IV Lefetamine (SPA)
US: CSA Schedule IV Section f Subsection 12 SPA
⇒
PubChem: 22779; ChemSpider: 21356; Bluelight: Lefetamine; Drugs Forum: Lefetamine; Wikipedia: Lefetamine
Effective 11 Dec 2003, SOR/2003-412 added:
32.
Amineptine (7-[(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof
UK: MDA Part III Class C Section 1(a) Amineptine
UN: Psychotropics Schedule II Amineptine
Effective 30 Mar 2012, SOR/2012-66 added:
33.
Benzylpiperazine (BZP; 1-Benzylpiperazine) and its salts, isomers and salts of isomers
EU: Substances Substances 1-Benzylpiperazine
UK: MDA Part III Class C Section 1(ca) 1-Benzylpiperazine
US: CSA Schedule I Section f Subsection 2 N-Benzylpiperazine
Effective 30 Mar 2012, SOR/2012-66 added:
34.
Trifluoromethylphenylpiperazine (TFMPP; 1-(3-Trifluoromethylphenyl)piperazine) and its salts, isomers and salts of isomers
⇒
PubChem: 4296; ChemSpider: 4145; Bluelight: BZP + TFMPP; Drugs Forum: TFMPP; Erowid: TFMPP; Wikipedia: Trifluoromethylphenylpiperazine11 March 2016 · 
· Isomer Design
· Isomer Design